State of Wyoming Takes $924,000 Position in Grail, Inc. (NASDAQ:GRAL)

State of Wyoming bought a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 51,747 shares of the company's stock, valued at approximately $924,000. State of Wyoming owned about 0.15% of Grail as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Crcm LP bought a new position in Grail in the fourth quarter valued at about $65,061,000. Sessa Capital IM L.P. bought a new position in Grail in the fourth quarter valued at about $53,550,000. Primecap Management Co. CA bought a new position in Grail in the fourth quarter valued at about $37,118,000. Baker BROS. Advisors LP bought a new position in Grail in the fourth quarter valued at about $29,098,000. Finally, Vanguard Group Inc. bought a new position in Grail in the fourth quarter valued at about $25,902,000.

Analyst Ratings Changes

Several equities analysts have commented on GRAL shares. Canaccord Genuity Group increased their target price on Grail from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th. Morgan Stanley increased their target price on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th.

Grail Price Performance

Shares of Grail stock traded down $1.86 during midday trading on Wednesday, reaching $37.46. The company had a trading volume of 1,000,858 shares, compared to its average volume of 1,256,695. The stock has a fifty day moving average price of $30.41 and a 200 day moving average price of $27.00. The firm has a market cap of $1.35 billion and a PE ratio of -0.61. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($3.10) EPS for the quarter, topping analysts' consensus estimates of ($4.03) by $0.93. The company had revenue of $31.84 million during the quarter, compared to analyst estimates of $35.80 million. As a group, sell-side analysts forecast that Grail, Inc. will post -15.15 EPS for the current year.

Insiders Place Their Bets

In other Grail news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.21, for a total value of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at approximately $25,862,541.02. The trade was a 0.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, President Joshua J. Ofman sold 2,109 shares of Grail stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $31.20, for a total value of $65,800.80. Following the completion of the sale, the president now owns 559,673 shares of the company's stock, valued at approximately $17,461,797.60. The trade was a 0.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 194,948 shares of company stock worth $6,583,130. 1.85% of the stock is owned by corporate insiders.

About Grail

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.